DE

David Michael Evans

KL Kalvista Pharmaceuticals Limited: 4 patents #1 of 7Top 15%
PR Proximagen: 1 patents #4 of 11Top 40%
SI Sirnaomics: 1 patents #1 of 5Top 20%
📍 Welwyn Garden City, MD: #1 of 1 inventorsTop 100%
Overall (2021): #24,147 of 548,734Top 5%
6
Patents 2021

Issued Patents 2021

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDate
11198691 N-((het)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors Rebecca Louise Davie, Hannah Joy Edwards, Simon Teanby Hodgson 2021-12-14
11180484 Pyrazole derivatives as plasma kallikrein inhibitors Rebecca Louise Davie, Hanna Joy Edwards, Simon Teanby Hodgson, Stephen John Pethen, David Philip Rooker 2021-11-23
11084809 N-((HET)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors Rebecca Louise Davie, Hannah Joy Edwards, Simon Teanby Hodgson 2021-08-10
11058779 Sirna/nanoparticle formulations for treatment of middle-east respiratory syndrome coronaviral infection Patrick Y. Lu, Vera Simonenko, Yibin Cai, John J. Xu 2021-07-13
11001578 N-((HET)arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors Rebecca Louise Davie, Hannah Joy Edwards, Simon Teanby Hodgson 2021-05-11
10968223 Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitors Max Espensen, Lee Patient, Iain Simpson, Edward Savory 2021-04-06